Heart and Vascular
FINALITY
Heart Failure
A randomized, double-blind, placebo-controlled pragmatic study to evaluate FINerenone on clinicAL effIcacy and safeTY in patients with Heart Failure and reduced ejection fraction who are intolerant of or not eligible for treatment with steroidal mineralocorticoid receptor antagonists
Contact Research Team:
[email protected]
Site principal investigator:
Andrew Sauer, MD
Learn more about this study:
NCT06033950